Massive Alzheimer's registry launches to monitor drug safety in 2,000 patients
NCT ID NCT07420075
First seen Feb 22, 2026 · Last updated May 25, 2026 · Updated 18 times
Summary
This study is a registry that collects information from about 2,000 people with mild cognitive impairment or Alzheimer's disease. Researchers will observe how the disease progresses and how treatments are used in everyday medical care. No new drugs or procedures are given; the goal is to better understand Alzheimer's and improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.